Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Lipoprotein(a): A Risk Factor and Biomarker in Heart Failure
Author(s): Anna Kowalczys , Joanna Marlęga-Linert , Marcin Gruchała , et al Added: 1 month ago

Imaging & Diagnostics

Prevention & Chronic Conditions
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 7 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 9 months ago

CV Disease in Special Populations

Heart Failure
Pre-implant Right Ventricular dP/dt Can Predict Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation
Author(s): Parth Visrodia , Aniket S Rali , Gabriel Hernandez , et al Added: 7 months ago

Imaging & Diagnostics

Heart Failure
Advancing Heart Failure Care: Timely Referral and Life‑prolonging Strategies with HeartMate 3 Left Ventricular Assist Device
Author(s): Sanjeev Gulati Added: 6 months ago

Heart Failure
Definitions and Implications of Shock Diagnosis and Therapy with Dr Frederick Welt
Author(s): Frederick Welt Added: 8 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Intervention

MI/ACS
Hyperkalaemia in the Cardiorenal Patient - Navigating Guidelines & Real-World Data
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
AHA 25: HFpEF as an Adipose Tissue Disorder
Author(s): Milton Packer Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Job title: Associate Physician
Dr Michelle O’Donoghue, is an Associate Physician in the Cardiology Division of Brigham and Women’s Hospital, an Affiliate Physician in the Cardiology Division of Massachusetts General Hospital and an Assistant Professor in Medicine at Harvard Medical School in Boston, Massachusetts, US. She is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, founded by Dr Eugene… View more
HFA 2026: AC01 in HFrEF — Safety and Efficacy from GOAL-HF1
Author(s): Lars H Lund Added: 3 weeks ago
HFA Congress 2026 — Dr Lars Lund (Karolinska Institute and Karolinska University Hospital, Stockholm, SE) joins us to discuss findings from GOAL-HF1, a randomised, double-blind, placebo-controlled phase 1b/2a trial evaluating AC01 in patients with heart failure with reduced ejection fraction (HFrEF).This first-in-patient study assessed the safety, tolerability and exploratory efficacy of AC01 — a… View more

Heart Failure